Design, synthesis, and docking study of new quinoline derivatives as antitumor agents
作者:Eman E. Nasr、Amany S. Mostafa、Magda A. A. El‐Sayed、Mohammed A. M. Massoud
DOI:10.1002/ardp.201800355
日期:2019.7
New quinolines substituted with various heterocycles and chalcone moieties were synthesized and evaluated as antitumor agents. All the synthesized compounds were in vitro screened against 60 human cancer cell lines. Compound 13 showed the highest cytotoxicity toward 58 cell lines, exhibiting distinct growth inhibition values (GI50) against the majority of them, including SR, HL‐60 (TB) strains (leukemia)
合成了各种杂环和查耳酮部分取代的新喹啉,并作为抗肿瘤剂进行了评估。所有合成的化合物都针对 60 种人类癌细胞系进行了体外筛选。化合物 13 对 58 种细胞系显示出最高的细胞毒性,对大多数细胞系表现出不同的生长抑制值 (GI50),包括 SR、HL-60 (TB) 菌株(白血病)和 MDA-MB-435 菌株(黑色素瘤), GI50 值分别为 0.232、0.260 和 0.300 µM。它对癌细胞系表现出很大的选择性,对以皮肤成纤维细胞(BJ)和乳腺上皮细胞系(MCF-10F)为代表的正常细胞的毒性作用较小。化合物 13 对拓扑异构酶 1 (Topo 1) 的酶抑制活性进行了评价,表皮生长因子受体和血管内皮生长因子受体 2,与作为参考药物的喜树碱 (IC50 0.224 µM) 相比,它显示出有价值的 Topo 1 抑制活性,IC50 值为 0.278 µM。进行对接研究以研究具有 Topo